BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
UFP Technologies
UFPT
$2.59B
| $26.1M | ﹤0.01% |
454,069
-18,141
| -4% | -$985K |
|
|
GRTS
3127
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $26.1M | ﹤0.01% |
2,854,868
+458,092
| +19% | +$4.24M |
|
3128
Forte Biosciences
FBRX
$1.57B
| $26.1M | ﹤0.01% |
31,005
+20,538
| +196% | +$18.5M |
|
|
TRML
3129
DELISTED
Tourmaline Bio
TRML
| $26M | ﹤0.01% |
+177,313
| New | +$27.2M |
|
|
GOLD
3130
Gold.com Inc
GOLD
$1.24B
| $26M | ﹤0.01% |
1,118,508
+569,766
| +104% | +$12.7M |
|
3131
MVB Financial
MVBF
$401M
| $26M | ﹤0.01% |
608,526
+4,723
| +0.8% | +$193K |
|
3132
Daily Journal
DJCO
$827M
| $25.9M | ﹤0.01% |
76,544
-488
| -0.6% | -$157K |
|
3133
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $25.9M | ﹤0.01% |
665,905
+303,967
| +84% | +$12.1M |
|
3134
iShares International Treasury Bond ETF
IGOV
$1.54B
| $25.7M | ﹤0.01% |
492,681
-382,095
| -44% | -$20.2M |
|
|
TA
3135
DELISTED
TravelCenters of America LLC
TA
| $25.6M | ﹤0.01% |
877,175
+554,028
| +171% | +$15.4M |
|
3136
NWPX Infrastructure Inc
NWPX
$1.22B
| $25.5M | ﹤0.01% |
903,832
+11,649
| +1% | +$370K |
|
3137
Century Casinos
CNTY
$34.3M
| $25.5M | ﹤0.01% |
1,899,061
-175,825
| -8% | -$2.3M |
|
|
PSTX
3138
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $25.5M | ﹤0.01% |
2,541,825
-284,731
| -10% | -$2.55M |
|
3139
Applied Optoelectronics
AAOI
$10.6B
| $25.4M | ﹤0.01% |
2,995,675
-1,060,467
| -26% | -$8.63M |
|
|
EVLO
3140
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $25.3M | ﹤0.01% |
92,175
+10,688
| +13% | +$2.7M |
|
3141
Tejon Ranch
TRC
$451M
| $25.3M | ﹤0.01% |
1,664,585
+65,912
| +4% | +$1.02M |
|
3142
Eterna Therapeutics
ERNA
$5.16M
| $25.3M | ﹤0.01% |
+187
| New | +$26.9M |
|
3143
Bridgewater Bancshares
BWB
$584M
| $25.3M | ﹤0.01% |
1,563,452
-115,781
| -7% | -$1.94M |
|
3144
Zevra Therapeutics
ZVRA
$622M
| $25.2M | ﹤0.01% |
1,968,378
+1,909,495
| +3,243% | +$20.5M |
|
3145
Altimmune
ALT
$597M
| $25.2M | ﹤0.01% |
2,557,242
+1,499,055
| +142% | +$20.5M |
|
|
SEI
3146
Solaris Energy Infrastructure
SEI
$3.55B
| $25.1M | ﹤0.01% |
2,581,249
-14,589
| -0.6% | -$155K |
|
3147
Cue Biopharma
CUE
$112M
| $25M | ﹤0.01% |
71,627
-3,296
| -4% | -$1.28M |
|
|
BRFS
3148
DELISTED
BRF SA
BRFS
| $25M | ﹤0.01% |
4,572,036
-2,427,027
| -35% | -$11.6M |
|
|
CSSE
3149
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $24.9M | ﹤0.01% |
602,280
+594,228
| +7,380% | +$20.9M |
|
|
MGP
3150
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $24.9M | ﹤0.01% |
680,546
+99,590
| +17% | +$3.55M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.